{"schema_version":"secwatch.filing_event.v1","accession":"0001649094-26-000026","form_type":"8-K","ticker":"PCVX","cik":"0001649094","company_name":"Vaxcyte, Inc.","filed_at":"2026-06-23T20:09:09+00:00","discovered_at":"2026-06-23T20:10:31.366170+00:00","generated_at":"2026-06-23T20:10:38.108555+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Vaxcyte director Jacks Lee retires; Moncef Slaoui appointed to board","bullets":["Jacks Lee retired from the Board effective June 17, 2026; no disagreement with the company.","Lee entered a consulting agreement for global strategic supply and manufacturing operations.","Moncef Slaoui appointed as Class II director effective June 17, 2026; term expires at 2028 annual meeting.","Slaoui deemed independent under Nasdaq rules; will receive standard non-employee director compensation with annual equity grant valued at $430,000."],"urls":{"canonical":"https://secwatch.observer/filing/0001649094-26-000026","json":"https://secwatch.observer/filing/0001649094-26-000026.json","markdown":"https://secwatch.observer/filing/0001649094-26-000026.md","text":"https://secwatch.observer/filing/0001649094-26-000026.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1649094/000164909426000026/0001649094-26-000026-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1649094/000164909426000026/pcvx-20260617.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T20:10:38.108555+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"d5f307af46","claim":"Moncef Slaoui was appointed as Class II Director at Vaxcyte, Inc..","evidence_excerpt":"On June 17, 2026, upon recommendation of the Nominating and Corporate Governance Committee of the Board, the Board appointed Moncef Slaoui to the Board as a Class II director, which appointment became effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909426000026/0001649094-26-000026-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Class II Director"}],"fact_type":"executive_change"},{"claim_id":"f0473ec423","claim":"Jacks Lee retired as Director at Vaxcyte, Inc..","evidence_excerpt":"On June 17, 2026, Jacks Lee notified the Board of Directors (the “Board”) of Vaxcyte, Inc. (“the “Company”) of his retirement from the Board, effective as of June 17, 2026.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909426000026/0001649094-26-000026-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"retired"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}